National Biodiversity Authority releases Rs. 15.52 crore ABS Proceeds from Mustard Genetic Resources

The release of Rs. 15.52 crore in Access and Benefit Sharing (ABS) proceeds by the National Biodiversity Authority (NBA) marks a significant milestone in India's implementation of the Biological Diversity Act, 2002, and its international obligations under the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization (2010). This case involves M/s. Pioneer Overseas Corporation, which developed ten commercial mustard (Brassica juncea) hybrid varieties using India's biological resources — specifically, parental lines sourced from the open market and traders rather than directly from identifiable farmers or communities. Because no single provider could be traced, the NBA constituted an Expert Committee to devise a fair disbursal mechanism, ultimately deciding to distribute the ABS amount among 26 State Biodiversity Boards (SBBs) and 3 Union Territory Biodiversity Councils (UTBCs) in proportion to each State's share of national mustard cultivation area, based on data from ICAR–Indian Institute of Rapeseed-Mustard Research (ICAR-IIRMR), Bharatpur. Rajasthan, accounting for nearly 42% of India's mustard area, received the highest share (Rs. 6.43 crore), followed by Uttar Pradesh (Rs. 2.28 crore) and Madhya Pradesh (Rs. 1.86 crore). This development must be understood in historical context. The Biological Diversity Act, 2002, was enacted to give effect to the Convention on Biological Diversity (CBD), 1992, which India ratified in 1994. The Act establishes a three-tier structure: the National Biodiversity Authority (NBA) at the Centre, State Biodiversity Boards (SBBs), and Biodiversity Management Committees (BMCs) at the local level. Section 32 of the Act mandates that ABS funds be used for conservation, documentation of People's Biodiversity Registers (PBRs), in-situ and ex-situ conservation, restoration of degraded ecosystems, strengthening Biodiversity Heritage Sites, capacity building of BMCs, and improving community livelihoods. The current disbursal aligns with Target 13 of the Kunming-Montreal Global Biodiversity Framework (GBF), adopted at CBD COP15 in 2022, which calls for fair and equitable benefit-sharing from the use of genetic resources. The stakeholders are diverse: the NBA as the statutory regulator under the Ministry of Environment, Forest and Climate Change (MoEFCC); SBBs and UTBCs as implementing agencies; ICAR-IIRMR as the scientific data provider; and the private sector (Pioneer Overseas Corporation) as the user of genetic resources. The case sets a precedent for ABS when resources are accessed via intermediaries — a common scenario in commercial agriculture. Economically, it demonstrates that India's genetic resources have tangible commercial value, and that benefit-sharing can generate substantial funds for sub-national conservation. Politically, it reinforces cooperative federalism by channeling resources to States based on objective, scientific criteria. Socially, it empowers local communities through BMCs and PBRs, linking biodiversity stewardship to livelihood improvement. Constitutionally, the Act draws on Article 48A (Directive Principle: protection and improvement of environment and safeguarding of forests and wildlife) and Article 51A(g) (Fundamental Duty: to protect and improve the natural environment). The distribution mechanism also reflects the spirit of fiscal federalism under Article 280 (Finance Commission), though ABS is not a tax devolution. Internationally, India's compliance with the Nagoya Protocol — which entered into force in 2014 — enhances its standing in global biodiversity governance and supports its leadership in forums like the CBD and the International Treaty on Plant Genetic Resources for Food and Agriculture (ITPGRFA). Looking ahead, this case may catalyze more ABS agreements as private companies increasingly tap into India's agro-biodiversity. The NBA's cumulative ABS releases of Rs. 182.5 crore (with Rs. 116.22 crore in the last 12 months alone) signal growing momentum. Future implications include: stronger incentives for States to document and conserve genetic resources; potential disputes over cultivation-area data; need for digital tracking of genetic resource use; and alignment with the proposed amendments to the Biological Diversity Act (Biological Diversity (Amendment) Bill, 2021) aimed at easing compliance while safeguarding benefit-sharing. For aspirants, this case is a living example of how domestic law, international treaties, federal architecture, and market dynamics intersect in environmental governance.